News | June 05, 2014

Record-Breaking 2,874 Abstracts Submitted to ASTRO’s 56th Annual Meeting

June 5, 2014 — The American Society for Radiation Oncology (ASTRO) has garnered a record-breaking total of 2,874 abstracts submitted for selection for the 56th annual meeting: 1,681 studies are from researchers in the United States, followed by 575 studies from Asia [Japan (206), China (191), Korea (93), Taiwan (33), India (31), Hong Kong (8), Singapore (7), Philippines (3), Thailand (2) and Malaysia (1)]; 171 studies from Canada; 54 studies from Germany; and 31 studies from the United Kingdom. The scientific presentations will include up to four plenary papers, 360 oral presentations, 1,862 posters and 144 digital posters in more than 50 educational sessions and for 20 disease-site tracks and topics including radiation biology, radiation physics, palliative care, patient safety and patient-reported outcomes.

The 2014 annual meeting will be held Sept. 14-17, at San Francisco’s Moscone Center, and is expected to attract more than 11,000 attendees including oncologists from all disciplines, medical physicists, dosimetrists, radiation therapists, radiation oncology nurses and nurse practitioners, biologists, physician assistants, practice administrators, industry representatives and other healthcare professionals from around the world.

Led by ASTRO President Bruce G. Haffty, M.D., FASTRO, the theme of the 2014 meeting is “Targeting Cancer: Technology and Biology.” The Presidential Symposium, “Local-regional Management of Breast Cancer: A Changing Paradigm,” will feature Jay R. Harris, M.D., FASTRO, and Thomas A. Buchholz, M.D., FASTRO, to highlight recent practice-changing landmark studies and current developments in the local-regional management of breast cancer.

Three keynote speakers will address a range of topics including oncologic imaging, biology and targeting in oncology, and human error and safety concerns: 

  • Hedvig Hricak, M.D., Ph.D., chair, department of radiation oncology, Memorial Sloan Kettering Cancer Center;
  • Frank McCormick, Ph.D., FRS, director, University of California San Francisco Helen Diller Family Comprehensive Cancer Center; and
  • Sidney Dekker, Ph.D., professor, Safety Science Innovation Lab, Griffith University, Brisbane, Australia.


For more information: www.astro.org

Related Content

ASTRO and ASCO Launch New Cancer Care Quality Registry
News | Radiation Therapy | January 22, 2018
January 22, 2018 — A registry that tracks the quality of medical care provided to patients receiving cancer treatment
First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
Overlay Init